You are using an unsupported browser. Please upgrade your browser to a newer version to get the best experience on GWAS-ROCS Database.

Browsing Study Simulations

Displaying study simulation 426 - 450 of 579 in total
GWAS-ROCS ID Condition/Phenotype | GWAS Central ID PubMed IDSNPs (p-value)Heritability AUROC ROC Plot
GR00418Periodontitis | HGVRS644225672891
  • rs2392510 (4.0e-06)
  • rs9446777 (5.0e-06)
0.0050.536328Gr00418
GR00419Peripheral artery disease | HGVRS650225009551
  • rs653178 (6.0e-07)
0.0000.501862Gr00419
GR00420Plantar fascial disorders | HGVRS525429534260
  • rs62051384 (2.0e-08)
0.0000.50608Gr00420
GR00421Polycystic ovary syndrome | HGVRS135921151128
  • rs13429458 (2.0e-23)
  • rs12478601 (3.0e-23)
  • rs13405728 (8.0e-21)
  • rs2479106 (8.0e-19)
  • rs10818854 (9.0e-18)
0.0210.572619Gr00421
GR00422Primary biliary cholangitis | HGVRS149721399635
  • rs7774434 (4.0e-34)
  • rs17129789 (9.0e-20)
  • rs10931468 (2.0e-19)
  • rs12531711 (9.0e-17)
  • rs485499 (2.0e-16)
  • rs12134279 (2.0e-14)
  • rs3745516 (2.0e-13)
  • rs8017161 (3.0e-13)
  • rs6421571 (3.0e-12)
  • rs12924729 (3.0e-12)
  • rs7665090 (4.0e-12)
  • rs860413 (1.0e-11)
  • rs911263 (2.0e-11)
  • rs2293370 (3.0e-11)
  • rs11117432 (5.0e-11)
  • rs538147 (2.0e-10)
  • rs968451 (1.0e-09)
  • rs1800693 (2.0e-09)
  • rs1372072 (2.0e-08)
  • rs6974491 (4.0e-08)
  • rs7208487 (8.0e-07)
  • (show allshow less)
0.0900.649846Gr00422
GR00423Primary biliary cholangitis | HGVRS260623000144
  • rs4979462 (3.0e-14)
  • rs4938534 (2.0e-08)
0.0530.615111Gr00423
GR00424Primary biliary cholangitis | HGVRS567628062665
  • rs4979462 (8.0e-19)
  • rs9303277 (8.0e-11)
  • rs7404928 (4.0e-09)
  • rs6897932 (6.0e-09)
  • rs4938534 (1.0e-08)
  • rs230534 (1.0e-07)
  • rs2293370 (1.0e-06)
  • rs644587 (1.0e-06)
  • (show allshow less)
0.0460.607684Gr00424
GR00425Primary biliary cholangitis | HGVRS64219458352
  • rs6441286 (2.0e-14)
  • rs3790567 (3.0e-11)
  • rs4679904 (1.0e-06)
  • rs907092 (8.0e-06)
0.0250.579467Gr00425
GR00426Primary open-angle glaucoma | HGVRS123120835238
  • rs4236601 (2.0e-11)
0.0040.531609Gr00426
GR00427Primary sclerosing cholangitis | HGVRS135621151127
  • rs3197999 (1.0e-16)
  • rs6720394 (4.0e-08)
0.0100.550039Gr00427
GR00428Progressive supranuclear palsy | HGVRS159921685912
  • rs8070723 (2.0e-118)
  • rs1768208 (5.0e-17)
  • rs12203592 (6.0e-15)
  • rs7571971 (4.0e-13)
  • rs1411478 (4.0e-11)
  • rs6687758 (6.0e-08)
  • rs11568563 (7.0e-08)
  • rs6852535 (1.0e-07)
  • rs2142991 (3.0e-07)
  • (show allshow less)
0.3770.806983Gr00428
GR00429Progressive supranuclear palsy | HGVRS160021685912
  • rs6547705 (1.0e-08)
0.0110.551468Gr00429
GR00430Progressive supranuclear palsy | HGVRS160121685912
  • rs242557 (9.0e-18)
0.0120.554059Gr00430
GR00431Prostate cancer | HGVRS14818264096
  • rs4242382 (3.0e-19)
  • rs10993994 (7.0e-13)
  • rs6983267 (7.0e-12)
  • rs4430796 (1.0e-09)
  • rs10896449 (2.0e-09)
  • rs4962416 (2.0e-07)
  • rs10486567 (2.0e-06)
  • (show allshow less)
0.0060.539553Gr00431
GR00432Prostate cancer | HGVRS15619117981
  • rs9623117 (5.0e-07)
0.0100.549873Gr00432
GR00433Prostate cancer | HGVRS164421602798
  • rs7210100 (3.0e-13)
0.0030.52631Gr00433
GR00434Prostate cancer | HGVRS165821743467
  • rs2242652 (3.0e-24)
  • rs10936632 (7.0e-22)
  • rs10187424 (3.0e-15)
  • rs10875943 (7.0e-12)
  • rs7584330 (3.0e-09)
  • rs5919432 (1.0e-08)
  • rs6763931 (2.0e-08)
  • rs130067 (3.0e-08)
  • rs2121875 (4.0e-08)
  • (show allshow less)
0.0010.513372Gr00434
GR00435Prostate cancer | HGVRS20718264098
  • rs5945572 (4.0e-13)
  • rs721048 (8.0e-09)
0.0030.52888Gr00435
GR00436Prostate cancer | HGVRS258023023329
  • rs103294 (5.0e-16)
  • rs817826 (5.0e-14)
0.0040.53343Gr00436
GR00437Prostate cancer | HGVRS262022923026
  • rs6983561 (4.0e-13)
  • rs13254738 (4.0e-10)
  • rs12653946 (3.0e-07)
  • rs1512268 (5.0e-06)
0.0440.605042Gr00437
GR00438Prostate cancer | HGVRS262122923026
  • rs10090154 (3.0e-06)
0.0070.540721Gr00438
GR00439Prostate cancer | HGVRS354623535732
  • rs1933488 (4.0e-18)
  • rs6062509 (4.0e-16)
  • rs684232 (5.0e-15)
  • rs8008270 (2.0e-14)
  • rs7611694 (4.0e-13)
  • rs1894292 (5.0e-13)
  • rs12155172 (5.0e-13)
  • rs4245739 (2.0e-11)
  • rs11568818 (2.0e-11)
  • rs1270884 (7.0e-11)
  • rs11135910 (8.0e-11)
  • rs2405942 (2.0e-10)
  • rs7141529 (3.0e-10)
  • rs3850699 (5.0e-10)
  • rs7241993 (2.0e-09)
  • rs11650494 (2.0e-09)
  • rs3096702 (5.0e-09)
  • rs3771570 (5.0e-09)
  • rs2273669 (8.0e-09)
  • rs1218582 (2.0e-08)
  • rs11902236 (3.0e-08)
  • rs2427345 (4.0e-08)
  • rs6869841 (5.0e-08)
  • (show allshow less)
0.0090.546772Gr00439
GR00440Prostate cancer | HGVRS422326307654
  • rs76010824 (1.0e-07)
  • rs140659849 (1.0e-07)
  • rs114997855 (1.0e-07)
  • rs723557 (6.0e-07)
0.0020.519966Gr00440
GR00441Prostate cancer | HGVRS519523104005
  • rs188140481 (6.0e-34)
0.0240.57764Gr00441
GR00442Prostate cancer | HGVRS567226034056
  • rs11986220 (4.0e-45)
  • rs6983267 (3.0e-27)
  • rs77541621 (2.0e-26)
  • rs11263763 (5.0e-24)
  • rs6983561 (6.0e-22)
  • rs1016343 (6.0e-21)
  • rs10993994 (7.0e-21)
  • rs376592364 (6.0e-20)
  • rs4646284 (1.0e-19)
  • rs10896449 (5.0e-19)
  • rs142463603 (4.0e-16)
  • rs7501939 (4.0e-15)
  • rs1512268 (4.0e-15)
  • rs2659124 (1.0e-13)
  • rs10086908 (2.0e-12)
  • rs9364554 (6.0e-12)
  • rs10486567 (3.0e-11)
  • rs7808935 (3.0e-11)
  • rs8071558 (7.0e-11)
  • rs16902104 (5.0e-10)
  • rs116041037 (6.0e-10)
  • rs3731827 (1.0e-09)
  • rs5759167 (2.0e-09)
  • rs1859962 (2.0e-09)
  • rs10187424 (3.0e-09)
  • rs2735839 (6.0e-09)
  • rs72725879 (3.0e-08)
  • rs7679673 (5.0e-08)
  • rs10875943 (7.0e-08)
  • rs902774 (9.0e-08)
  • rs11649743 (6.0e-07)
  • rs339331 (6.0e-07)
  • rs13252298 (2.0e-06)
  • rs17599629 (9.0e-06)
  • (show allshow less)
0.0780.63985Gr00442
Displaying study simulation 426 - 450 of 579 in total